The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results